Mandatory Principal Prepayment. Upon the occurrence of any Change in Control, all outstanding principal and accrued but unpaid interest under this Note shall be due and payable and, at the election of Payee, shall be (i) paid in cash by the Maker, or (ii) converted into shares of the common stock of Maker at a price per share equal to One Dollar ($1.00) (the “Conversion Price”).
Appears in 2 contracts
Sources: Convertible Secured Term Note (Bone Biologics Corp), Convertible Secured Term Note (Bone Biologics Corp)